Otherwise I cannot understand why they are not run
Post# of 154105
_____________________
Perhaps, because leronlimab is too good and thus is too dangerous to too many powerful interests.


CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.